House Subcommittee Postpones Pediatric Antidepressant Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
A conflict caused the Energy & Commerce/Oversight Subcommittee to postpone a July 20 hearing on clinical trial publication and disclosure issues. Results from a new study evaluating suicidal behavior in patients taking SSRIs versus tricyclic antidepressants could be a topic of discussion during the rescheduled hearing.